Profile
TCRX NVO VRTX REGN SGEN ARGX
Company Name TScan Therapeutics, Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $162.25M $387.18B $103.71B $76.98B $43.15B $37.13B
Employees 0.19K 71.88K 5.40K 14.17K 3.26K 1.15K
CEO Dr. Gavin MacBeath Ph.D. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
TCRX NVO VRTX REGN SGEN ARGX
Quant Rating Score 2 3 3 4 3 1
Quant Rating Sell Neutral Neutral Buy Neutral Strong Sell
Trading
TCRX NVO VRTX REGN SGEN ARGX
Last Close $3.04 $86.02 $402.7 $712.33 $228.74 $615
High 52 $9.51 $146.91 $516.74 $1201.76 $228.74 $638.33
Low 52 $2.85 $85 $392.81 $701.85 $228.74 $356.01
Price vs. 52 Week High -68.03 % -41.45 % -22.07 % -40.73 % 0 % -3.65 %
Price vs. 52 Week Low 6.67 % 1.2 % 2.52 % 1.49 % 0 % 72.75 %
Total Return
TCRX NVO VRTX REGN SGEN ARGX
1 Month Return -37.32 % -20.84 % -13.53 % -6.56 % 0 % -0.4 %
3 Month Return -41.98 % -26.15 % -12.86 % -31.52 % 0 % 11.82 %
6 Month Return -46.95 % -39.84 % -15 % -31.81 % 0 % 41.22 %
9 Month Return -57.78 % -31.98 % -1.64 % -25.39 % 0 % 54.87 %
YTD Return 0 % 0 % 0 % 0 % 0 % 0 %
1 Year Return -46.76 % -15.77 % -2 % -21.29 % 0 % 61.44 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
TCRX NVO VRTX REGN SGEN ARGX
Dividend Yield Percentage (TTM) - 1.55 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -31.47 % 1.25 % -2.62 % 4.88 % -2.27 % -2.22 %
Dividend Per Share (TTM) - 9.9 % - - - -
Payout Ratio (TTM) - 46.6 % - - - -
Growth
TCRX NVO VRTX REGN SGEN ARGX
Asset Growth 36.7 % 30.35 % 25.23 % 13.23 % -1.21 % 44.93 %
Gross Profit Growth -899.05 % 32.32 % 9.64 % 6.49 % 22.93 % 190.7 %
Revenue Growth 55.52 % 31.26 % 10.51 % 7.76 % 24.65 % 198.56 %
Revenue 3 Year 637.51 % 90.03 % 60.36 % 55.67 % 91.56 % 2071.96 %
Revenue 5 Year - 123.63 % 219.55 % 110.3 % 215.48 % 3041.46 %
Revenue 10 Year - 65.69 % 610.45 % 549.62 % 494.04 % 9009.53 %
EBIT Growth -40.25 % 37.11 % 0 % -14.6 % 10.13 % 40.94 %
Net Income Growth -35.58 % 50.71 % 8.96 % -8.87 % 9.51 % 58.42 %
Net Income 3 Yeari Growth Per Share -30.34 % 106.26 % 34.59 % 13.48 % -763.59 % 64.01 %
Net Income 5 Yeari Growth Per Share -158.79 % 133.27 % 70.33 % 74.02 % -276.93 % -143.65 %
Net Income 10 Yeari Growth Per Share -158.79 % 98.1 % 809.6 % 871.12 % -624.16 % -857 %
Operating Income Growth -40.25 % 37.11 % 0 % -14.6 % 10.13 % 40.94 %
Operating Cash Flow Growth (CFG) 7.74 % 38.06 % -14.35 % -8.39 % 9.07 % 51.28 %
Operating 3 Year CFG -671.61 % 117.73 % 9.63 % 76.95 % -147.99 % 21.71 %
Operating 5 Year CFG -86.28 % 162.84 % 174.78 % 125.17 % -195.86 % -329.63 %
Operating 10 Year CFG -86.28 % 150.28 % 6084.35 % 713.56 % -2622.09 % -1280.2 %
EPS Growth 50.36 % 51.88 % 8.33 % -8.54 % 10.81 % 60.46 %
EPS Diluted Growth 50.36 % 52.37 % 8.35 % -9.03 % 10.81 % 60.46 %
Book Value Per Share -44.38 % 28.67 % 25.58 % 15.03 % -9.83 % 38.53 %
Share Holder 3 Year Equity Growth Per Share 235.07 % 74.77 % 104.06 % 137.56 % 33.72 % 93.75 %
Share Holder 5 Year Equity Growth Per Share 434.66 % 121.34 % 291.14 % 219.1 % 220.81 % 318.81 %
Share Holder 10 Year Equity Growth Per Share 434.66 % 49.24 % 1030.79 % 1286.9 % 691.19 % 3654.06 %
Dividend Per Share Growth - 26.56 % - - - -
Dividend 3 Year Growth Per Share - 63.98 % - - - -
Dividend 5 Year Growth Per Share - 79.57 % - - - -
Dividend 10 Year Growth Per Share - 94.94 % - - - -
Debt Growth 7.5 % 4.74 % 44.1 % 0.06 % -23.28 % 60.95 %
Free Cash Flow Growth 8.8 % 9.17 % -16.47 % -17.11 % 3.67 % 51.98 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022 31 Dec 2023
Profitability
TCRX NVO VRTX REGN SGEN ARGX
Gross Profit Margin TTM 61.01 % 84.66 % 86.1 % 84.42 % 72.37 % 86.82 %
Return on Assets TTM -31.98 % 23.83 % -2.16 % 12.43 % -11.76 % -2.13 %
Return on Equity TTM -58.72 % 86.4 % -2.88 % 16.85 % -16.53 % -2.75 %
Return on Capital Employed TTM -37.41 % 62.74 % -1.72 % 11.85 % -16.87 % -8.98 %
Net Income Per EBT TTM 100 % 79.43 % -184.82 % 93.66 % 100.55 % 167.72 %
EBT Per Ebit TTM 93.17 % 100.52 % -82.68 % 124.1 % 94.01 % 15.76 %
EBIT Per Revenue TTM -1276.07 % 43.84 % -2.96 % 28.92 % -36.09 % -17.08 %
Cash Flow To Debt Ratio TTM -349.71 % 207.5 % - 214.08 % -185.98 % -
Receivables Turnover TTM - 3.89 6.06 2.27 1.98 3.45
Payables Turnover TTM 1 1.72 3.73 4.34 1.54 1.06
Inventory Turnover TTM - 1.09 1.37 0.71 0.65 0.91
Fixed Asset Turnover TTM 13.95 % 225.8 % 422.11 % 311.93 % 256.83 % 6116.64 %
Asset Turnover TTM 2.69 % 68.08 % 47.71 % 36.98 % 34.46 % 47.09 %
Operating Cash Flow Per Share TTM -0.9 26.54 -3.27 39.29 -1.12 -2.42
Free Cash Flow Per Share TTM -0.93 15.14 -4.51 31.25 -1.62 -3.52
Cash Per Share TTM 228.41 % 1681.33 % 2528.88 % 9062.44 % 657.5 % 5163.05 %
Operating Cash Flow Sales Ratio TTM -1144.8 % 43.69 % -7.94 % 30.67 % -16.85 % -6.44 %
Free Cash Flow Operating Cash Flow Ratio TTM 103.18 % 57.03 % 138.12 % 79.52 % 144.14 % 145.12 %
Cash Flow Coverage Ratios TTM -349.71 % 207.5 % - 214.08 % -185.98 % -
Price To Free Cash Flows Ratio TTM -1.47 41.92 -89.11 22.79 -141.85 -175.77
Price To Operating Cash Flows Ratio TTM -3.37 24.01 -123.3 18.13 -203.89 -253.9
Price Cash Flow Ratio TTM -3.37 24.01 -123.3 18.13 -203.89 -253.9
Income Statement (TTM)
TCRX NVO VRTX REGN SGEN ARGX
Revenue $0.02B $232.26B $9.87B $13.12B $1.96B $1.23B
Gross Profit $-0.07B $196.5B $8.61B $11.3B $1.55B $1.11B
Gross Profit Ratio -318.8% 84.6% 87.21% 86.16% 79.1% 90.39%
EBITDA $-0.08B $114.63B $4.61B $4.69B $-0.62B $-0.22B
Net Income $-0.09B $83.68B $3.62B $3.95B $-0.61B $-0.3B
EPS Diluted -1.36 18.62 13.89 34.77 -3.3 -5.16
Balance Sheet (MRQ)
TCRX NVO VRTX REGN SGEN ARGX
Long Term Debt $0.09B $20.53B $0.72B $2.7B $0.04B $0.02B
Total Liabilities $0.12B $207.93B $5.15B $7.11B $0.87B $0.44B
Total Equity $0.15B $106.56B $17.58B $25.97B $2.8B $4.1B
Total Investments $0.06B $17.5B $3.45B $13.51B $1.42B $1.18B
Total Debt $0.09B $27.01B $0.81B $2.7B $0.04B $0.02B
Total Assets $0.27B $314.49B $22.73B $33.08B $3.67B $4.54B
Cash Flow Statement (TTM)
TCRX NVO VRTX REGN SGEN ARGX
Net Income $-0.09B $83.68B $3.62B $3.95B $-0.61B $-0.43B
Inventory $0B $-7.42B $-0.32B $-0.27B $-0.23B $-0.08B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.06B $108.91B $3.54B $4.59B $-0.45B $-0.42B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.08B $-0.04B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 3.15
ABCL AbCellera Biologics Inc. 3.025
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.91
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.86
ABPWW 0.0853
ABSI Absci Corporation 2.705
ABUS Arbutus Biopharma Corporation 3.3
ABVC ABVC BioPharma, Inc. 0.6413
ABVX Abivax SA American Depositary Shares 7.3
ACAD ACADIA Pharmaceuticals Inc. 18.66
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.9737
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.1401
ACHV Achieve Life Sciences, Inc. 3.7
ACIU AC Immune SA 2.84
ACLX Arcellx, Inc. 78.71
ACRV Acrivon Therapeutics, Inc. Common Stock 5.7
ETFs With Exposure to TCRX
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00422 221.12
VTI Vanguard Total Stock Market Index Fund 0 289.29
IBB iShares Biotechnology ETF 0.0132 132.88
IWN iShares Russell 2000 Value ETF 0.0031 163.92
IWV iShares Russell 3000 ETF 0.0004 333.82
IWO iShares Russell 2000 Growth ETF 0.00545 288.95
BIB ProShares Ultra Nasdaq Biotechnology 0.00524255 51.0242
VXF Vanguard Extended Market Index Fund 0 190.36
HDG ProShares Hedge Replication ETF 0.000607685 49.4523
UWM ProShares Ultra Russell2000 0.00175873 41.91
VTHR Vanguard Russell 3000 Index Fund 0 259.29
IWC iShares Micro-Cap ETF 0.02733 130.53
DWAS Invesco DWA SmallCap Momentum ETF 0.245 91.7449
URTY ProShares UltraPro Russell2000 0.000818499 49.35
VTWV Vanguard Russell 2000 Value Index Fund 0 144.295
GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF 0 68.96
VTWG Vanguard Russell 2000 Growth Index Fund 0.01 210.935
VTWO Vanguard Russell 2000 Index Fund 0.01 89.4
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 99.1
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 99.08
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 48.49
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 48.48
VBINX Vanguard Balanced Index Fund Investor Shares 0 48.49
BMED BlackRock Future Health ETF 0.16792 24.96
DFAU Dimensional US Core Equity Market ETF 0.00011374 40.43
IBBQ Invesco Nasdaq Biotechnology ETF 0.015 21.5482
DFUS Dimensional U.S. Equity ETF 0.0000504 63.645
DFAT Dimensional U.S. Targeted Value ETF 0.00102449 55.49
DFAS Dimensional U.S. Small Cap ETF 0.00106607 64.97
DFAC Dimensional U.S. Core Equity 2 ETF 0.00009844 34.555
VTSAX Vanguard Total Stock Market Index Fund 0 141.03
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.0148 6.3425
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 144.07
VITSX Vanguard Total Stock Market Index Fund 0 141.05
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.0148 6.332
DFSU Dimensional US Sustainability Core 1 ETF 0.00060886 37.8
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000809312 99.09
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 144.08
AVSC Avantis U.S. Small Cap Equity ETF 0 54.17
SURI Simplify Propel Opportunities ETF 4.4597 16.0999
DCOR Dimensional ETF Trust 0.00051132 63.99
VEMPX Vanguard Extended Market Index InstlPlus 0 355.55
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 264.58
RSSL Global X Funds 0 86.76
DXUV Dimensional ETF Trust 0.00003072 52.79
RFLR Innovator ETFs Trust 0.02 25.7099
Unlock